Related references
Note: Only part of the references are listed.A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma
Keren Porper et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
Chin-Hsiao Tseng
BIOMOLECULES (2021)
Metformin: Ongoing Journey with Superdrug Revolution
Amr Ahmed El-Arabey et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Drug Repurposing of Metabolic Agents in Malignant Glioma
Corinna Seliger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases
Leandro Fornias Machado de Rezende et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2018)
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut
Jacobo de la Cuesta-Zuluaga et al.
DIABETES CARE (2017)
Metabolic syndrome in relation to risk of meningioma
Corinna Seliger et al.
ONCOTARGET (2017)
Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis
Kunal Maniar et al.
MEDICAL HYPOTHESES (2017)
A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Kunal Maniar et al.
PHARMACOLOGICAL RESEARCH (2017)
Diabetes, use of metformin, and the risk of meningioma
Corinna Seliger et al.
PLOS ONE (2017)
Metformin and lung cancer risk in patients with type 2 diabetes mellitus
Chin-Hsiao Tseng
ONCOTARGET (2017)
Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis
C. -H. Tseng
DIABETES & METABOLISM (2017)
Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment
Feifei Cheng et al.
CLINICAL ENDOCRINOLOGY (2016)
Activation of multiple growth factor signalling pathways is frequent in meningiomas
David A. Hilton et al.
NEUROPATHOLOGY (2016)
Activation of AMPK α2 inhibits airway smooth muscle cells proliferation
Lu Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Epidemiology of Brain Tumors
Katharine A. McNeill
NEUROLOGIC CLINICS (2016)
Molecular targets of metformin antitumor action
Stanislaw Sosnicki et al.
PHARMACOLOGICAL REPORTS (2016)
Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms
Yang Song et al.
PHARMACOLOGICAL RESEARCH (2016)
Body mass index, physical activity, and risk of adult meningioma and glioma A meta-analysis
Tobias Niedermaier et al.
NEUROLOGY (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
Jichang Wang et al.
ONCOTARGET (2015)
Smoking and risk of meningioma: A meta-analysis
Zuoxu Fan et al.
CANCER EPIDEMIOLOGY (2013)
The performance of different propensity score methods for estimating marginal hazard ratios
Peter C. Austin
STATISTICS IN MEDICINE (2013)
Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
Chin-Hsiao Tseng
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Share Paper
